EdgarLookup

ABVC BIOPHARMA, INC. — 8-K Filings

250 8-K filings on record

This page lists all 8-K filings submitted to the SEC by ABVC BIOPHARMA, INC. (ABVC), sorted by most recent first. Each row links to the full filing on EdgarLookup. ABVC BIOPHARMA, INC. has filed 250 8-K documents with the SEC since 2002. To view all SEC filings by ABVC BIOPHARMA, INC., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-KT 10-Q 10-Q/A 10KSB 10KSB/A 10QSB 3 3/A 4 4/A 424B1 424B2 424B3 424B4 424B5 5 8-A12B 8-K 8-K/A AW CERT CORRESP D DEF 14A DEFA14A EFFECT NT 10-K NT 10-Q POS AM PRE 14A PREM14A RW S-1 S-1/A S-1MEF S-3 S-3/A S-4 S-4/A S-8 S-8 POS SB-2 SB-2/A SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
8-K CURRENT REPORT 0001213900-23-014358 Feb 24, 2023
8-K CURRENT REPORT 0001213900-23-012464 Feb 16, 2023
8-K CURRENT REPORT 0001213900-22-065540 Oct 21, 2022
8-K CURRENT REPORT 0001213900-22-055465 Sep 13, 2022 Sep 12, 2022
8-K CURRENT REPORT 0001213900-22-055075 Sep 9, 2022 Sep 4, 2022
8-K CURRENT REPORT 0001213900-22-050070 Aug 22, 2022 Aug 19, 2022
8-K CURRENT REPORT 0001213900-22-039422 Jul 14, 2022
8-K CURRENT REPORT 0001213900-22-033890 Jun 21, 2022
8-K CURRENT REPORT 0001213900-22-030570 Jun 1, 2022 May 27, 2022
8-K CURRENT REPORT 0001213900-22-029554 May 25, 2022 May 20, 2022
8-K CURRENT REPORT 0001213900-22-027389 May 17, 2022 May 16, 2022
8-K CURRENT REPORT 0001213900-22-025731 May 12, 2022 May 11, 2022
8-K CURRENT REPORT 0001213900-22-021801 Apr 27, 2022
8-K CURRENT REPORT FILING 0001213900-22-016733 Mar 31, 2022
8-K CURRENT REPORT 0001213900-22-011339 Mar 9, 2022
8-K CURRENT REPORT 0001213900-22-008631 Feb 22, 2022
8-K CURRENT REPORT 0001213900-21-052090 Oct 8, 2021
8-K CURRENT REPORT 0001213900-21-040497 Aug 5, 2021
8-K CURRENT REPORT 0001213900-21-008287 Feb 11, 2021 Feb 8, 2021
8-K CURRENT REPORT 0001213900-21-001202 Jan 8, 2021
8-K FORM 8-K 0001213900-21-000903 Jan 7, 2021
8-K CURRENT REPORT 0001213900-20-037753 Nov 17, 2020 Oct 23, 2020
8-K CURRENT REPORT 0001213900-20-035298 Nov 5, 2020 Oct 30, 2020
8-K CURRENT REPORT 0001213900-20-030246 Oct 6, 2020 Sep 30, 2020
8-K CURRENT REPORT 0001213900-20-013988 Jun 3, 2020 May 29, 2020
8-K CURRENT REPORT 0001213900-20-011668 May 11, 2020
8-K CURRENT REPORT 0001213900-20-010040 Apr 24, 2020 Apr 20, 2020
8-K CURRENT REPORT 0001213900-20-009167 Apr 14, 2020 Apr 5, 2020
8-K CURRENT REPORT 0001213900-20-008785 Apr 7, 2020 Apr 2, 2020
8-K CURRENT REPORT 0001213900-20-007946 Mar 30, 2020
8-K CURRENT REPORT 0001213900-19-025476 Dec 6, 2019 Dec 5, 2019
8-K CURRENT REPORT 0001213900-19-021840 Nov 1, 2019 Oct 29, 2019
8-K FORM 8-K 0001213900-19-020388 Oct 15, 2019
8-K CURRENT REPORT 0001213900-19-020182 Oct 11, 2019 Oct 10, 2019
8-K CURRENT REPORT 0001213900-19-018286 Sep 17, 2019 Sep 11, 2019
8-K 8-K 0001213900-19-017248 Sep 5, 2019 Aug 28, 2019
8-K CURRENT REPORT 0001213900-19-016730 Aug 27, 2019 Aug 21, 2019
8-K CURRENT REPORT 0001213900-19-015469 Aug 13, 2019 Aug 4, 2019
8-K FORM 8-K 0001213900-19-014661 Aug 6, 2019 Aug 1, 2019
8-K CURRENT REPORT 0001213900-19-014345 Aug 1, 2019 May 30, 2019
8-K CURRENT REPORT 0001213900-19-012615 Jul 12, 2019 Jun 30, 2019
8-K CURRENT REPORT 0001213900-19-012050 Jul 3, 2019 Jun 28, 2019
8-K CURRENT REPORT 0001213900-19-009469 May 23, 2019
8-K CURRENT REPORT 0001213900-19-008025 May 8, 2019 May 3, 2019
8-K CURRENT REPORT 0001213900-19-002622 Feb 14, 2019 Feb 8, 2019
8-K CURRENT REPORT 0001213900-19-001553 Feb 1, 2019 Jan 21, 2019
8-K CURRENT REPORT 0001213900-18-005806 May 10, 2018 May 4, 2018
8-K CURRENT REPORT 0001213900-18-002840 Mar 12, 2018
8-K CURRENT REPORT 0001213900-18-001834 Feb 14, 2018
8-K CURRENT REPORT 0001213900-18-001268 Feb 5, 2018 Jan 31, 2018